Mental Health and Suicidal Ideation in HIV-Positive Populations

HIV-positive populations experience elevated rates of depression, anxiety and suicidal ideation driven by intersecting biological, psychosocial and structural factors. Epidemiological surveys indicate that between 8% and 33% of people living with HIV contemplate suicide at various stages of their care, with risk peaking at diagnosis, during treatment interruptions and in contexts of pronounced stigma. Psychosocial stressors—such as self-stigma, social isolation, financial hardship and co-occurring mental disorders like major depressive episodes—amplify feelings of hopelessness and undermine adherence to antiretroviral therapy (ART). Marginalised subgroups—women facing gendered discrimination, men who have sex with men subject to minority stress and people who inject drugs confronting addiction—are particularly vulnerable. Qualitative studies highlight that shock at diagnosis, fear of transmission to family and anticipation of community rejection can precipitate acute crises of meaning. In many low- and middle-income countries, limited access to mental health services exacerbates these risks. Integrated models of HIV care that embed routine mental health screening, stigma-reduction initiatives and cognitive rehabilitation to bolster executive function have shown promise in reducing suicidal ideation and improving linkage to care. Globally, addressing mental health within HIV programmes is essential to mitigate suicide as a preventable cause of mortality and to achieve comprehensive patient-centred care.

Research from Nature Portfolio

A large cohort analysis of adults diagnosed with HIV revealed that suicide and accidental injury account for over one-fifth of non-AIDS deaths. Crucially, statistical modelling demonstrated that delayed diagnosis and late initiation of highly active antiretroviral therapy interact on both additive and multiplicative scales to heighten mortality risk, indicating that timely HIV detection and early ART uptake substantially reduce suicide-related fatalities. These insights underscore the importance of optimising testing strategies and accelerating treatment initiation to prevent avoidable deaths in people living with HIV.

Mental Health and Suicidal Ideation in HIV-Positive Populations publication trend

The graph below shows the total number of articles in mental health and suicidal ideation in hiv-positive populations across all publications each year (not limited to Nature Index journals).

Technical terms

Antiretroviral therapy (ART): Medication regimen used to suppress HIV replication and restore immune function.

Suicidal ideation: Thoughts about self-harm or ending one’s life, ranging from fleeting considerations to detailed planning.

Self-stigma: Internalisation of negative beliefs and emotions about oneself arising from membership of a stigmatised group.

Executive function: Cognitive processes—including working memory, inhibitory control and cognitive flexibility—that regulate thought and behaviour.

Syndemic: Co-occurrence and interaction of multiple health problems or epidemics that exacerbate overall disease burden.

References

1. An exploratory qualitative study of the psychological effects of HIV diagnosis; the need for early involvement of mental health professionals to improve linkage to care. BMC Public Health (2023).
2. The mediating role of executive function in the relationship between self-stigma and self-injury or suicidal ideation among men who have sex with men living with HIV. Frontiers in Public Health (2023).
3. “I Was Very Shocked, I Wanted It to Be Over”: A Qualitative Exploration of Suicidal Ideation and Attempts among Women Living with HIV in Indonesia. International Journal of Environmental Research and Public Health (2023).
4. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health (2011).
5. HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006–2013. Scientific Reports (2017).